La vacunación contra el COVID-19 en el mundo se llevará a cabo a través de diferentes empresas farmacéuticas. Moderna, de origen estadounidense, brinda una vacuna con una logística distribución sencilla, la cual requiere un almacenamiento de 2 a 8 grados Celsius (36 a 46 grados Fahrenheit) durante 30 días. Esa es la temperatura que se […]
Continue Reading-
Promoting Health Equity During COVID-19
Special thanks to NFID Director Julie Morita, MD, executive vice president of the Robert Wood Johnson Foundation for this guest blog post on applying health equity principles to the COVID-19 response. Dr. Morita served on the Biden-Harris Transition COVID-19 Advisory Board and previously helped lead the Chicago Department of Public Health for nearly two decades. […]
Continue Reading -
COVID-19 Vaccine: Phase 1a
The Food and Drug Administration (FDA) has authorized the Pfizer-BioNTech COVID-19 vaccine and the Moderna COVID-19 vaccine for emergency use to be distributed across the nation. The Centers for Disease Control and Prevention (CDC) recommends that healthcare workers and residents in long-term care facilities be offered the vaccine first in phase 1a, followed by elders age 75 and older […]
Continue Reading